Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-19
2011-04-19
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S237200, C514S239500, C544S111000, C544S141000
Reexamination Certificate
active
07928103
ABSTRACT:
Compounds of formula (I) are disclosed. Compounds according to the invention are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
REFERENCES:
patent: 3966809 (1976-06-01), Baker et al.
patent: 7595397 (2009-09-01), Zindell et al.
patent: 2007/0191340 (2007-08-01), Zindell et al.
patent: 2008/0039464 (2008-02-01), Berry et al.
patent: 2008/0081822 (2008-04-01), Berry et al.
patent: 2009/0275611 (2009-11-01), Riether et al.
patent: 2010/0009964 (2010-01-01), Berry et al.
patent: 2010/0029644 (2010-02-01), Riether et al.
patent: 2010/0076029 (2010-03-01), Bartolozzi et al.
patent: 2010/0081644 (2010-04-01), Bartolozzi et al.
patent: 2010/0261708 (2010-10-01), Cirillo et al.
patent: 2004/018433 (2004-03-01), None
patent: 2006/095159 (2006-09-01), None
patent: 2007/070760 (2007-06-01), None
patent: 2007118041 (2007-10-01), None
patent: 2008014199 (2008-01-01), None
patent: 2008039645 (2008-04-01), None
patent: 2008048914 (2008-04-01), None
patent: 2008064054 (2008-05-01), None
patent: 2008098025 (2008-08-01), None
patent: 2009055357 (2009-04-01), None
patent: 2009061652 (2009-05-01), None
patent: 2009105509 (2009-08-01), None
patent: 2009140089 (2009-11-01), None
patent: 2010036630 (2010-04-01), None
patent: 2010036631 (2010-04-01), None
patent: 2010077836 (2010-07-01), None
patent: 2010096371 (2010-08-01), None
patent: 2010147791 (2010-12-01), None
patent: 2010147792 (2010-12-01), None
Igarashi J and Kobayashi Y, “Improved synthesis of quinine alkaloids with the Teoc protective group,” Tetrahedron Letters, Sep. 2005, 46(37), 6381-6384.
International Search Report for PCT/US2007/081342 mailed Mar. 3, 2008.
Cartwright, D., et al., “Abnormal Nucleophillic substitution in 3-trichloromethylpyridine, its N-oxide and 3,5-Bis(trichloromethyl)pyridine”. Tetrahedron, Elsevier Science Publishers, Amsterdam, vol. 51, No. 47, 1995, pp. 12791-12796.
Gartst, M., et al., “Hydroformylation of bisolefinic amine derivatives catalyzed by cobalt and rhodium”. Journal of Organic Chemistry, vol. 46, 1981, pp. 4433-4438.
J. Igarashi, et al., “Improved synthesis of quinine alkaloids with the Teoc protective group”. Tetrahedron letters, Elsevier, Amsterdam, vol. 46, No. 37, 2005, pp. 6381-6384.
Yordanova, K. et al. “New method for the synthesis of 2,4-disubstituted morpho-lines”. Chemical Abstracts, vol. 97, No. 17, Oct. 25, 1982, Columbus, Ohio, USA Chemical Abstracts, vol. 97, No. 17, Oct. 25, 1982, Columbus, Ohio, vol. 115, No. 7, pp. 2635-2642.
Riether Doris
Thomson David Smith
Zindell Renee M.
Boehringer Ingelheim International GmbH
Bottino Anthony P.
Hui San-ming
Morris Michael P.
Zarek Paul
LandOfFree
Compounds which modulate the CB2 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds which modulate the CB2 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds which modulate the CB2 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2663691